SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

Joshua A. Hill(Fred Hutch Cancer Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Kinga Hosszu, Mehdi Hamadani(Medical College of Wisconsin), John M. McCarty(Virginia Commonwealth University), Kavita V. Bhavsar(Medical College of Wisconsin), Elad Sharon(National Cancer Institute), Susan DeWolf(Memorial Sloan Kettering Cancer Center), Lik Wee Lee(Institute for Systems Biology), Aliyah Baluch(Moffitt Cancer Center), Zainab Shahid(Memorial Sloan Kettering Cancer Center), Lee M. Greenberger(Enzon Pharmaceuticals (United States)), Joseph P. McGuirk(University of Kansas Medical Center), Stephanie Waldvogel(National Marrow Donor Program), Jo‐Anne H. Young(University of Minnesota System), Ashley Spahn(National Marrow Donor Program), Kristin Peyton(Emmes (United States)), Jianqun Kou(East Tennessee State University), Paul M. Armistead(University of North Carolina at Chapel Hill), Jeffery J. Auletta(Nationwide Children's Hospital), Amir A. Toor(Virginia Commonwealth University), Ryotaro Nakamura(City Of Hope National Medical Center), Madhav V. Dhodapkar(Emory University), Mary M. Horowitz(Medical College of Wisconsin), Min Chen(Jiangsu University), Michael J. Martens(Medical College of Wisconsin), Peter Westervelt(MACOM (United States)), Marcie Riches(Medical College of Wisconsin)
EClinicalMedicine
April 27, 2023
Cited by 25


Related Papers